Total Funding
62
62
Total FundingVenture - Series Unknown raised
Growth Score 62 in past quarter
-3 pts
Heat Score 62 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
108801
Infusense is pioneering a biosensor platform for drug quantification.
Eric Kriegstein: CEOPast Role: Signatures Capital, Principal
Edward Chaum: Founder and Chief Medical Officer
About the Company
Infusense's platform uses electrochemistry to rapidly and accurately quantify lipophilic drugs to address unmet needs for clinical and industrial applications.
